#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute on chronic liver failure Gastrointestinal stromal tumour Wolfram syndrome Liposarcoma recurrent Brain abscess Chronic myelomonocytic leukaemia Glycogen storage disease type I Alport's syndrome Glomerulonephritis Frontotemporal dementia Neuroendocrine tumour Infantile spasms Short stature Skin cancer Obliterative bronchiolitis More trials…

    Learn about Rare Diseases

    Alport’s syndrome – Diagnostics Testicular leiomyosarcoma – Diagnostics Fabry’s disease – Trials in Disease Vascular malformation – Trials in Disease Hepatic angiosarcoma – Treatment Primary mediastinal large B-cell lymphoma – Life with Disease Acquired haemophilia Mantle cell lymphoma stage III – Trials in Disease Glomerulonephritis rapidly progressive – Life with Disease Mast cell activation syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dexamethasone Ph. Eur. Nitrogen Selgantolimod Dacarbazine Citrate Mecillinam AMO959 INCB123667 Sarilumab Zanubrutinib Pf-06835375 Amlitelimab Glibenclamide Lomustine Donepezil Sevoflurane Ifinatamab Deruxtecan Brigatinib Betamethasone Dog Epithelium Extract Bi-1910 More therapies…

    Learn about Your Condition

    Apheresis Ovarian cancer metastatic Thyroid cancer Chronic sinusitis Congenital ureteric anomaly Corneal graft failure Osteoporosis postmenopausal Peptostreptococcus infection Chordoma Prader-Willi syndrome Dyspepsia Monogenic diabetes Diffuse large B-cell lymphoma Ataxia telangiectasia Alopecia areata More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Diabetes mellitus

  • Study of Denosumab Effects on Muscle Strength and Insulin Sensitivity in Patients with Postmenopausal Osteoporosis and Diabetes Mellitus

    Recruiting

    3 1 1
    Investigated Diseases:
    • Osteoporosis postmenopausal
    • Diabetes mellitus
    Investigated Drugs:
    • Denosumab
    • Saline
    Denmark

  • Study on the Effects of Empagliflozin, Pioglitazone, and Semaglutide for Patients with Type 2 Diabetes

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Diabetes mellitus
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Pioglitazone
    • Empagliflozin
    • Semaglutide
    Denmark Sweden

  • Study on the Effect of Semaglutide in Patients with Type 1 Diabetes and Insulin Resistance

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Diabetes mellitus
    Investigated Drugs:
    • Semaglutide
    France

  • Effect of liraglutide on immune response to pneumococcal polysaccharide vaccine in adults with diabetes

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Diabetes mellitus
    Investigated Drugs:
    • Pneumococcal Polysaccharide Serotype 17F
    • Pneumococcal Polysaccharide Serotype 2
    • Pneumococcal Polysaccharide Serotype 20
    The Netherlands

  • A Study of Semaglutide for Diabetic Patients with Heart Attack or Unstable Angina to Measure Changes in Coronary Artery Plaque Using Imaging

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute coronary syndrome
    • Diabetes mellitus
    Investigated Drugs:
    • Semaglutide
    Italy

  • Study on Switching to Insulin Glargine 300 U/ml from Insulin Glargine 100 U/ml for Patients with Type 2 Diabetes and Kidney Problems

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Diabetes mellitus
    Spain
Previous Page
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!